1303 related articles for article (PubMed ID: 17048973)
1. Guidelines on paediatric dosing on the basis of developmental physiology and pharmacokinetic considerations.
Bartelink IH; Rademaker CM; Schobben AF; van den Anker JN
Clin Pharmacokinet; 2006; 45(11):1077-97. PubMed ID: 17048973
[TBL] [Abstract][Full Text] [Related]
2. Optimizing pediatric dosing: a developmental pharmacologic approach.
Anderson GD; Lynn AM
Pharmacotherapy; 2009 Jun; 29(6):680-90. PubMed ID: 19476420
[TBL] [Abstract][Full Text] [Related]
3. Lean body mass as a predictor of drug dosage. Implications for drug therapy.
Morgan DJ; Bray KM
Clin Pharmacokinet; 1994 Apr; 26(4):292-307. PubMed ID: 8013162
[TBL] [Abstract][Full Text] [Related]
4. Developmental pharmacokinetics.
Anderson GD
Semin Pediatr Neurol; 2010 Dec; 17(4):208-13. PubMed ID: 21183126
[TBL] [Abstract][Full Text] [Related]
5. Principles of drug biodisposition in the neonate. A critical evaluation of the pharmacokinetic-pharmacodynamic interface (Part I).
Besunder JB; Reed MD; Blumer JL
Clin Pharmacokinet; 1988 Apr; 14(4):189-216. PubMed ID: 3292100
[TBL] [Abstract][Full Text] [Related]
6. Development and evaluation of a generic physiologically based pharmacokinetic model for children.
Edginton AN; Schmitt W; Willmann S
Clin Pharmacokinet; 2006; 45(10):1013-34. PubMed ID: 16984214
[TBL] [Abstract][Full Text] [Related]
7. Ontogeny of hepatic and renal systemic clearance pathways in infants: part II.
Alcorn J; McNamara PJ
Clin Pharmacokinet; 2002; 41(13):1077-94. PubMed ID: 12403644
[TBL] [Abstract][Full Text] [Related]
8. A mechanistic approach for the scaling of clearance in children.
Edginton AN; Schmitt W; Voith B; Willmann S
Clin Pharmacokinet; 2006; 45(7):683-704. PubMed ID: 16802850
[TBL] [Abstract][Full Text] [Related]
9. Vancomycin dosing in children and young adults: back to the drawing board.
Camaione L; Elliott K; Mitchell-Van Steele A; Lomaestro B; Pai MP
Pharmacotherapy; 2013 Dec; 33(12):1278-87. PubMed ID: 24019205
[TBL] [Abstract][Full Text] [Related]
10. Essentials for starting a pediatric clinical study (1): Pharmacokinetics in children.
Yokoi T
J Toxicol Sci; 2009; 34 Suppl 2():SP307-12. PubMed ID: 19571484
[TBL] [Abstract][Full Text] [Related]
11. Discontinuities and disruptions in drug dosage guidelines for the paediatric population.
Chitty KM; Chan B; Pulanco CL; Luu S; Egunsola O; Buckley NA
Br J Clin Pharmacol; 2018 May; 84(5):1029-1037. PubMed ID: 29411410
[TBL] [Abstract][Full Text] [Related]
12. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.
Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C
Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464
[TBL] [Abstract][Full Text] [Related]
13. The current state of knowledge on age, sex, and their interactions on clinical pharmacology.
Schwartz JB
Clin Pharmacol Ther; 2007 Jul; 82(1):87-96. PubMed ID: 17495875
[TBL] [Abstract][Full Text] [Related]
14. Pregnancy-induced changes in pharmacokinetics: a mechanistic-based approach.
Anderson GD
Clin Pharmacokinet; 2005; 44(10):989-1008. PubMed ID: 16176115
[TBL] [Abstract][Full Text] [Related]
15. Review of commonly used age-based weight estimates for paediatric drug dosing in relation to the pharmacokinetic properties of resuscitation drugs.
Carasco CF; Fletcher P; Maconochie I
Br J Clin Pharmacol; 2016 May; 81(5):849-56. PubMed ID: 26714256
[TBL] [Abstract][Full Text] [Related]
16. Prediction of cytochrome p450-mediated hepatic drug clearance in neonates, infants and children : how accurate are available scaling methods?
Björkman S
Clin Pharmacokinet; 2006; 45(1):1-11. PubMed ID: 16430308
[TBL] [Abstract][Full Text] [Related]
17. Clinical pharmacokinetics and pharmacodynamics of mycophenolate in solid organ transplant recipients.
Staatz CE; Tett SE
Clin Pharmacokinet; 2007; 46(1):13-58. PubMed ID: 17201457
[TBL] [Abstract][Full Text] [Related]
18. Clinical pharmacokinetics in infants and children. A reappraisal.
Kearns GL; Reed MD
Clin Pharmacokinet; 1989; 17 Suppl 1():29-67. PubMed ID: 2692939
[TBL] [Abstract][Full Text] [Related]
19. Pathophysiological and disease-induced changes in drug distribution volume: pharmacokinetic implications.
Klotz U
Clin Pharmacokinet; 1976; 1(3):204-18. PubMed ID: 797498
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics in the elderly.
Crooks J; O'Malley K; Stevenson IH
Clin Pharmacokinet; 1976; 1(4):280-96. PubMed ID: 797500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
